Corbus Pharmaceuticals Holdings Inc
CRBP
Market Cap$95.29M
Close$
$1.28
80.8% downside
Current Fair Value
80.8% downsideOvervalued by 80.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $95.29 Million |
|---|---|
| Enterprise Value | $81.33 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.68 |
| Beta | 3.13 |
| Outstanding Shares | 12,179,482 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.36 |
|---|---|
| PEG | -6.36 |
| Price to Sales | - |
| Price to Book Ratio | 0.6 |
| Enterprise Value to Revenue | 60.25 |
| Enterprise Value to EBIT | -1.83 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Corbus Pharmaceuticals Holdings Inc
CEO: Yuval Cohen